{
  "pmcid": "10416337",
  "sha256": "d8d0cfc447488b924933f090add34ebbf6f03b4f215c2689fe8c0990347e9d27",
  "timestamp_utc": "2025-11-09T23:06:45.652528+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.00362995594714,
    "reading_ease": 14.448234948605005,
    "word_count": 227
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Albuterol Spray in COPD Patients Undergoing General Anesthesia"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "randomized controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "120 smoking patients with COPD, aged 18-65 years"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to receive either albuterol spray (n=60) or placebo (n=60)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluated the effect of albuterol spray on hypoxia and bronchospasm in COPD patients under general anesthesia."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the occurrence of wheezing and bronchospasm, assessed perioperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomization was performed using block randomization, and allocation was concealed using sequentially numbered, opaque, sealed envelopes."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Both patients and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "randomly assigned to receive either albuterol spray (n=60) or placebo (n=60)"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Wheezing and recurrent cough were significantly lower in the albuterol group compared to the control group (p<0.05)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant side effects were reported in the albuterol group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: IRCT20170108031818N1."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 17,
    "max_score": 25
  }
}